Hexamidine

Hexamidine

SCHEMBL985947

N=C(N)c1ccc(OCCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 1.00
LMNA P02545 2/20 1.00
POLB P06746 2/20 1.00
RAB9A P51151 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
NPC1 O15118 1/20 1.00
MAPT P10636 1/20 1.00
ALOX15 P16050 1/20 1.00
BRCA1 P38398 1/20 1.00
HTT P42858 1/20 1.00
KDM4E B2RXH2 1/20 1.00
GMNN O75496 1/20 1.00
PKM P14618 1/20 1.00
THPO P40225 1/20 1.00
MTOR P42345 1/20 1.00
RECQL P46063 1/20 1.00
BLM P54132 1/20 1.00
HIF1A Q16665 1/20 1.00
PRMT1 Q99873 3/20 0.69
F2 P00734 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentamidine SCHEMBL33615 1.00 ALDH1A1 (1.00) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Hexamidine SCHEMBL128384 1.00 ALDH1A1 (1.00) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL27719324 1.00 ALDH1A1 (1.00) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL19462606 0.99 ALDH1A1 (0.97) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL5014184 0.99 ALDH1A1 (0.97) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL2658011 0.97 ALDH1A1 (0.95) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL23063972 0.96 ALDH1A1 (0.92) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Propamidine SCHEMBL293021 0.96 ALDH1A1 (0.92) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL16050177 0.94 ALDH1A1 (0.88) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
Pentamidine SCHEMBL18007221 0.94 ALDH1A1 (0.88) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
EP-4427123-B1 IMMERSIVE MEDIA STREAMING PRIORITIZED BY FREQUENCY OF ASSET REUSE Tencent America LLC (US) 2026-05-13 EP claimed
EP-4452116-B1 PLANNING METHODS FOR MODIFYING TOOL OPERATION BASED ON TISSUE PARAMETERS MAKO SURGICAL CORP (US) 2026-04-08 EP claimed
EP-4475533-B1 SYSTEMS AND METHODS FOR ADJUSTING BUFFER SIZE ADEIA GUIDES INC (US) 2026-03-25 EP claimed
EP-3758382-B1 SYSTEMS AND METHODS FOR ENSURING CONTINUED ACCESS TO MEDIA OF A PLAYLIST FOR MULTIPLE USERS ADEIA GUIDES INC (US) 2026-03-18 EP claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 US claimed
US-12521329-B2 Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl) butan-2-one, and cosmetic composition containing same L'OREAL (FR) 2026-01-13 US claimed
EP-3938962-B1 METHOD AND APPARATUS FOR UPDATING A NEURAL NETWORK DOLBY INT AB (IE) 2025-11-26 EP claimed
EP-4616840-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-09-17 EP claimed
WO-2022122930-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2022-06-16 WO claimed
WO-2022122137-A1 COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION SYMRISE AG (DE) 2022-06-16 WO claimed
WO-2022122135-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2022-06-16 WO claimed
WO-2022122898-A1 COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION SYMRISE AG (DE) 2022-06-16 WO claimed
EP-3996658-A1 ORAL CARE GUMMIES BASF SE (DE) 2022-05-18 EP claimed
US-11318073-B2 Low surfactant aerosol antidandruff composition THE PROCTER AND GAMBLE COMPANY (US) 2022-05-03 US claimed
CN-114366680-A Shampoo composition for maintaining scalp health, preventing alopecia and strengthening hair and preparation method thereof 北京幸福益生再生医学科技有限公司 2022-04-19 CN claimed
US-20220079145-A1 INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF WILSON JOHN PAUL (US) 2022-03-17 US claimed
WO-2022036113-A1 SEMI-PERMANENT TATTOOS inkbox ink Inc. (CA) 2022-02-17 WO claimed
CN-113979892-A Catalytic synthesis method of hexamidine and hexamidine diisethionate 东南大学成贤学院 2022-01-28 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent TLR7, MYC, ERG28 ALDH1A1 4611/4885LMNA 4342/4885POLB 2297/4885
US-11318073-B2 Low surfactant aerosol antidandruff composition SMURF1, ANXA1, ANXA3 ALDH1A1 4191/4885LMNA 3516/4885POLB 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.